Search For "latam markets"
Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], May 28 (ANI/BusinessWire India): Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and full-year ended March 31, 2022.
Read More